{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.35"},{"groupId":"OG001","value":"0.34"},{"groupId":"OG002","value":"0.39"},{"groupId":"OG003","value":"0.34"},{"groupId":"OG004","value":"0.30"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"864"},{"groupId":"OG001","value":"864"},{"groupId":"OG002","value":"862"},{"groupId":"OG003","value":"861"},{"groupId":"OG004","value":"861"}],"units":"Participants"}],"description":"Proportion of participants whose overall survival exceeded 5 years.","groups":[{"description":"Carboplatin AUC 6 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 8 cycles","id":"OG000","title":"Carbo/Taxol"},{"description":"Carboplatin AUC 5 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 8 cycles plus Gemcitabine 800 mg/m2/dIV on days 1 and 8 x 8 cycles","id":"OG001","title":"Carbo/Taxol/Gemcitabine"},{"description":"Carboplatin AUC 5 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 8 cycles plus Doxil 30 mg/m2 IV every other cycle on day 1 x 8 cycles","id":"OG002","title":"Carbo/Taxol/Doxil"},{"description":"Topotecan 1.25 mg/m2/dIV days 1-3 plus Carboplatin AUC 5 IV on day 3 plus x 4 cycles followed by Carboplatin AUC 6 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 4 cycles","id":"OG003","title":"Carbo/Topotecan - Carbo/Taxol"},{"description":"Gemcitabine 1000 mg/m2/dIV on days 1 and 8 plus Carboplatin AUC 6 IV on day 8 plus x 4 cycles followed by Carboplatin AUC 6 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 4 cycles","id":"OG004","title":"Carbo/Gemcitabine - Carbo/Taxol"}],"paramType":"NUMBER","populationDescription":"All enrolled participants.","reportingStatus":"POSTED","timeFrame":"Up to 9 years","title":"Overall Survival","type":"PRIMARY","unitOfMeasure":"Proportion of participants"}